GLENVIEW, IL – April 29, 2010. Governor Pat Quinn today announced an approximately $4 million investment package to assist Astellas Pharma US, Inc in establishing their new corporate headquarters for the Americas in Glenview. The state’s business package will leverage $140 million in private investment and will create 150 new jobs, further strengthening the economy of Northeast Illinois.
“I am pleased Astellas selected Illinois for its new headquarters for the Americas,” said Governor Quinn, who attended the company’s groundbreaking ceremony. “This major investment will create new jobs and generate economic activity throughout the region. At the same time, this decision highlights Illinois role as a Midwestern leader in the life sciences business and its emergence as a vital base of operation for the biopharmaceutical industry’s future growth.”
Construction of the new headquarters is scheduled to be completed in the spring of 2012. It will include two six-story buildings totaling 425,000 square feet. The buildings and site will emphasize sustainability and the complex is designed to achieve LEED Gold certification. The company’s current Deerfield-based employees will be relocating to the new headquarters.
"At Astellas, we measure success not only by bringing innovative and effective pharmaceuticals to patients and physicians, but also by our contributions to local communities and protection of the environment,” said Seigo Kashii, President and CEO of Astellas Pharma US, Inc. “Today we are fulfilling our vision for continued growth through our groundbreaking for a new corporate headquarters.”
The state’s investment package, administered by the Department of Commerce and Economic Opportunity (DCEO), will consist of Economic Development for a Growing Economy (EDGE) corporate income tax credits, which are based on job creation, and Employer Training Investment Program (ETIP) job training funds that will help enhance the skills of its workforce.
“In order for our economy to continue growing, we must continue making strategic investments on the local level that will create jobs and support long-term sustainable growth,” said DCEO Director Warren Ribley. “Our investment in Astellas will pay dividends for this region and the state.”
Astellas’ expansion will also support Illinois’ growing life sciences industry. Illinois’ biopharmaceutical industry, which is supported by the state’s highly-regarded federal labs and top-notch research universities, directly employs more than 40,000 people and supports more than 112,000 indirect and induced jobs.